Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit (DDOST), also known as OST48, is a critical non-catalytic subunit of the oligosaccharyltransferase (OST) complex located in the endoplasmic reticulum membrane (UniProt: P39656). Its primary biological function is to facilitate the transfer of a high-mannose oligosaccharide from a dolichol-linked donor to specific asparagine residues on nascent polypeptides, a process known as N-linked glycosylation (PubMed: 25524443). This modification is essential for proper protein folding, stability, and intracellular trafficking. Beyond its role in glycosylation, OST48 (as AGER1) is involved in the clearance of advanced glycation end-products (AGEs), which are linked to inflammatory and oxidative stress pathways in diabetes and kidney disease (PubMed: 21832108). Mutations in the DDOST gene lead to congenital disorder of glycosylation type Ih (DDOST-CDG), characterized by multi-systemic clinical features including developmental delay and hypotonia (OMIM: 602202). While not a common target for current clinical therapeutics, the OST complex is a subject of research for its potential in treating certain cancers and viral infections where glycosylation is a key factor in pathogenesis, with small molecules like NGI-1 serving as experimental inhibitors (PubMed: 28234446).
Inhibition of the oligosaccharyltransferase (OST) complex, thereby preventing the N-linked glycosylation of nascent proteins in the endoplasmic reticulum (PubMed: 28234446).
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit (DDOST) (OST48).